Literature DB >> 28872147

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure.

Zhongwei Sun1, Feng Li2, Xin Zhou2, Wen Wang3.   

Abstract

Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation and lung parenchymal destruction. It has a very high incidence in aging populations. The current conventional therapies for COPD focus mainly on symptom-modifying drugs; thus, the development of new therapies is urgently needed. Qualified animal models of COPD could help to characterize the underlying mechanisms and can be used for new drug screening. Current COPD models, such as lipopolysaccharide (LPS) or the porcine pancreatic elastase (PPE)-induced emphysema model, generate COPD-like lesions in the lungs and airways but do not otherwise resemble the pathogenesis of human COPD. A cigarette smoke (CS)-induced model remains one of the most popular because it not only simulates COPD-like lesions in the respiratory system, but it is also based on one of the main hazardous materials that causes COPD in humans. However, the time-consuming and labor-intensive aspects of the CS-induced model dramatically limit its application in new drug screening. In this study, we successfully generated a new COPD model by exposing mice to high levels of ozone. This model demonstrated the following: 1) decreased forced expiratory volume 25, 50, and 75/forced vital capacity (FEV25/FVC, FEV50/FVC, and FEV75/FVC), indicating the deterioration of lung function; 2) enlarged lung alveoli, with lung parenchymal destruction; 3) reduced fatigue time and distance; and 4) increased inflammation. Taken together, these data demonstrate that the ozone exposure (OE) model is a reliable animal model that is similar to humans because ozone overexposure is one of the etiological factors of COPD. Additionally, it only took 6 - 8 weeks, based on our previous work, to create an OE model, whereas it requires 3 - 12 months to induce the cigarette smoke model, indicating that the OE model might be a good choice for COPD research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28872147      PMCID: PMC5614366          DOI: 10.3791/56095

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  46 in total

1.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

2.  The effect of ozone and PM10 on hospital admissions for pneumonia and chronic obstructive pulmonary disease: a national multicity study.

Authors:  Mercedes Medina-Ramón; Antonella Zanobetti; Joel Schwartz
Journal:  Am J Epidemiol       Date:  2006-01-27       Impact factor: 4.897

3.  Bone marrow cells repair cigarette smoke-induced emphysema in rats.

Authors:  Jin Won Huh; Sun-Yong Kim; Ji Hyun Lee; Jin-Seok Lee; Quang Van Ta; Mijung Kim; Yeon-Mok Oh; Yun-Song Lee; Sang-Do Lee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-05-27       Impact factor: 5.464

Review 4.  Animal models of chronic obstructive pulmonary disease.

Authors:  Michael Fricker; Andrew Deane; Philip M Hansbro
Journal:  Expert Opin Drug Discov       Date:  2014-04-23       Impact factor: 6.098

Review 5.  New insights into the immunology of chronic obstructive pulmonary disease.

Authors:  Guy G Brusselle; Guy F Joos; Ken R Bracke
Journal:  Lancet       Date:  2011-09-10       Impact factor: 79.321

6.  Hydrogen Sulfide Prevents and Partially Reverses Ozone-Induced Features of Lung Inflammation and Emphysema in Mice.

Authors:  Feng Li; Pengyu Zhang; Min Zhang; Li Liang; Xiaoyuan Sun; Min Li; Yueqin Tang; Aihua Bao; Jicheng Gong; Junfeng Zhang; Ian Adcock; Kian Fan Chung; Xin Zhou
Journal:  Am J Respir Cell Mol Biol       Date:  2016-07       Impact factor: 6.914

7.  Air pollution and hospital admissions for chronic obstructive pulmonary disease in a tropical city: Kaohsiung, Taiwan.

Authors:  I-Ming Lee; Shang-Shyue Tsai; Chih-Ching Chang; Chi-Kung Ho; Chun-Yuh Yang
Journal:  Inhal Toxicol       Date:  2007-05       Impact factor: 2.724

Review 8.  Animal models of chronic obstructive pulmonary disease.

Authors:  Sandra Pérez-Rial; Álvaro Girón-Martínez; Germán Peces-Barba
Journal:  Arch Bronconeumol       Date:  2014-09-05       Impact factor: 4.872

9.  Effect of bosentan on the production of proinflammatory cytokines in a rat model of emphysema.

Authors:  Kilkil Gamze; Hamdi Muz Mehmet; Figen Deveci; Teyfik Turgut; Fulya Ilhan; Ibrahim Ozercan
Journal:  Exp Mol Med       Date:  2007-10-31       Impact factor: 8.718

Review 10.  Epidemiology of chronic obstructive pulmonary disease: a literature review.

Authors:  Catherine E Rycroft; Anne Heyes; Lee Lanza; Karin Becker
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-07-20
View more
  2 in total

1.  When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data.

Authors:  Jill M Pulley; Rebecca N Jerome; Nicole M Zaleski; Jana K Shirey-Rice; Andrea J Pruijssers; Robert R Lavieri; Somsundaram N Chettiar; Helen M Naylor; David M Aronoff; David A Edwards; Colleen M Niswender; Laura L Dugan; Leslie J Crofford; Gordon R Bernard; Kenneth J Holroyd
Journal:  Assay Drug Dev Technol       Date:  2017-12-01       Impact factor: 1.738

2.  Small-Airway Dysfunction is Involved in the Pathogenesis of Asthma: Evidence from Two Mouse Models.

Authors:  Yishu Xue; Wuping Bao; Yan Zhou; Qiang Fu; Huijuan Hao; Lei Han; Dongning Yin; Yingying Zhang; Xue Zhang; Min Zhang
Journal:  J Asthma Allergy       Date:  2021-07-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.